
For anyone having a stroke, every second matters. A delay in analysing a brain scan can be the difference between recovery and tragedy. That’s what Michalis Papadakis and Alastair Buchan’s medtech company, Brainomix, aims to prevent.

For anyone having a stroke, every second matters. A delay in analysing a brain scan can be the difference between recovery and tragedy. That’s what Michalis Papadakis and Alastair Buchan’s medtech company, Brainomix, aims to prevent.